Download PDF
Thromb Haemost 2006; 95(05): 912-913
DOI: 10.1160/TH06-01-0009
Letters to the Editor
Schattauer GmbH

Recurrent venous thromboembolism under anticoagulant therapy: A high risk in adenocarcinoma?

Renaud Descourt
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Grégoire Le Gal
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Francis Couturaud
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Dominique Mottier
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Luc Bressollette
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Gilles Robinet
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Christophe Rogé
2   Service de pneumologie, CH de Morlaix, Morlaix, France
,
Emmanuel Oger
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
,
Christophe Leroyer
1   Département de Médecine Interne et Pneumologie, EA 38 78, Hôpital de la Cavale Blanche, Brest, France
› Author AffiliationsFinancial support: This work is partially funded by the French Ministry of Health (“Projets Hospitaliers de recherche Clinique”).
Further Information

Publication History

Received 10 January 2006

Accepted after resubmission 09 March 2006

Publication Date:
01 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Heit JA, O’Fallon WM, Petterson TM. et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-8.
    CrossrefPubMedSearch in Google Scholar
  • 2 Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107 Suppl: (Suppl. 01) I17-I21.
    PubMedSearch in Google Scholar
  • 3 Blom JW, Doggen CJ, Osanto S. et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
    CrossrefPubMedSearch in Google Scholar
  • 4 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 Suppl: (Suppl. 03) 338S-400S.
    CrossrefPubMedSearch in Google Scholar
  • 5 Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2004; 02: 1760-5.
    CrossrefPubMedSearch in Google Scholar
  • 6 Lee A, Levine M. Treatment of venous thromboembolism in cancer patients. Cancer Control 2005; 12 Suppl: (Suppl. 01) 17-21.
    CrossrefPubMedSearch in Google Scholar
  • 7 Lee AY, Levine MN, Baker RI. et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
    CrossrefPubMedSearch in Google Scholar
  • 8 Lacut K, Oger E, Le Gal G. et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol 2004; 18: 477-82.
    CrossrefPubMedSearch in Google Scholar
  • 9 Linkins LA, Stretton R, Probyn L. et al. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res 2006; 117: 241-7.
    CrossrefPubMedSearch in Google Scholar
  • 10 Trousseau A. Phlegmatia alba dolens. Clinique médicale de l’Hôtel Dieu. Paris: 1861
    Search in Google Scholar
  • 11 Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002; 87: 575-9.
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Wahrenbrock M, Borsig L, Le D. et al. Selectinmucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 2003; 112: 853-62.
    CrossrefPubMedSearch in Google Scholar